Vincerx Pharma Ownership | Who Owns Vincerx Pharma?
Vincerx Pharma Ownership Summary
Vincerx Pharma is owned by 6.65% institutional investors, 18.06% insiders, and 75.29% retail investors. Citadel advisors is the largest institutional shareholder, holding 0.83% of VINC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.01% of its assets in Vincerx Pharma shares.
VINC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vincerx Pharma | 6.65% | 18.06% | 75.29% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Citadel advisors | 178.24K | 0.83% | $144.37K |
| State street | 57.02K | 0.27% | $46.18K |
| Blackrock | 47.08K | 0.22% | $38.13K |
| Millennium management | 11.45K | 0.05% | $9.27K |
| Renaissance | 22.10K | 0.05% | $5.81K |
| Lpl financial | 10.27K | 0.05% | $8.32K |
| Susquehanna group, llp | 21.37K | 0.05% | $5.62K |
| Morgan stanley | 1.75K | 0.01% | $1.42K |
| Bank of america corp /de/ | 210.00 | 0.00% | $170.00 |
| Point72 asset management | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Price t rowe associates inc /md/ | - | - | - |
| Geode capital management | - | - | - |
| Sage rhino capital | - | - | - |
| Renaissance | 22.10K | - | $5.81K |
| Marshall wace, llp | - | - | - |
| Point72 asset management | - | - | - |
| Blackrock | 47.08K | - | $38.13K |
| Tower research capital llc (trc) | - | - | - |
| Rubric capital management lp | - | - | - |
| Woodline partners lp | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 47.08K | - | - |
| State street | 57.02K | - | - |
| Citadel advisors | 178.24K | - | - |
| Qube research | - | - | -4.00 |
| Jpmorgan chase | - | - | -23.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Prosight management, lp | - | - | -2.21M |
| Sage rhino capital | - | - | -1.70M |
| Octagon capital advisors lp | - | - | -1.00M |
| Rock springs capital management lp | - | - | -891.72K |
| Bank of america corp /de/ | 210.00 | - | -701.21K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -4.00 |
| Jpmorgan chase | -23.00 |
| Wells fargo & company/mn | -160.00 |
| Macquarie group | -266.00 |
| Ica group wealth management | -300.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 18 | -30.77% | 3,037,760 | -72.43% | 6 | 1.14% | 5 | -61.54% | 8 | 100.00% |
| Sep 30, 2024 | 26 | -7.14% | 11,016,725 | 3.02% | 24 | 0.97% | 13 | 30.00% | 4 | -60.00% |
| Jun 30, 2024 | 28 | -24.32% | 10,694,191 | 26.44% | 49 | 3.20% | 10 | -50.00% | 10 | -16.67% |
| Mar 31, 2024 | 37 | 19.35% | 8,457,623 | -13.67% | 39 | 1.88% | 20 | 566.67% | 12 | 71.43% |
| Dec 31, 2023 | 31 | -11.43% | 9,796,408 | -8.47% | 45 | 1.81% | 3 | -72.73% | 7 | -41.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 341.07K | 1.01% | - |
| Vanguard US Total Market Shares ETF | 341.07K | 0.33% | - |
| Fidelity Extended Market Index | 14.86K | 0.28% | 7.79K |
| Vanguard Institutional Extnd Mkt Idx Tr | 14.02K | 0.27% | - |
| BlackRock Extended Equity Market K | 37.43K | 0.12% | -16.00 |
| Fidelity Series Total Market Index | 2.26K | 0.04% | 543.00 |
| Vanguard Instl Ttl Stck Mkt Idx Tr | 12.41K | 0.04% | 12.41K |
| Extended Equity Market Fund K | 1.85K | 0.04% | 5.00 |
| Fidelity Total Market Index | 1.55K | 0.03% | - |
| Spartan Extended Market Index Pool E | 984.00 | 0.02% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 11, 2023 | Seelenberger Alexander A. | See Remarks | Buy | $9.97K |
| Aug 09, 2023 | Hamdy Ahmed MD | See Remarks | Buy | $15.99K |
| Aug 10, 2023 | Hamdy Ahmed MD | See Remarks | Buy | $5.17K |
| Aug 10, 2023 | THOMAS TOM C | See Remarks | Buy | $4.75K |
| Aug 10, 2023 | Izumi Raquel E. | See Remarks | Buy | $3.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q3 | 6 | - |
| 2023 Q2 | - | - |
VINC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools